Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 5/20 | 0.50 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.50 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.50 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
| ▸ | AKT1 | P31749 | 2/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.44 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7365923 | 0.90 | HDAC8 (0.54) | DPP4OPRK1OPRD1SMYD3 | |
| SCHEMBL7364618 | 0.89 | OPRK1 (0.57) | DPP4DPP8DPP9DPP7AKT1 | |
| SCHEMBL7367542 | 0.89 | DPP4 (0.51) | DPP4DPP8DPP9DPP7F2 | |
| SCHEMBL7369343 | 0.86 | DPP4 (0.54) | DPP4DPP8DPP9DPP7AKT1 | |
| SCHEMBL7361820 | 0.85 | DPP4 (0.52) | DPP4DPP8DPP9DPP7F2 | |
| SCHEMBL7368941 | 0.79 | DPP4 (0.61) | DPP4DPP8DPP9DPP7F2 | |
| SCHEMBL7360569 | 0.79 | HDAC8 (0.55) | DPP4OPRK1OPRD1SMYD3 | |
| SCHEMBL5359350 | 0.77 | DPP4 (0.57) | DPP4DPP8DPP9DPP7AKT1 | |
| SCHEMBL7361667 | 0.77 | OPRK1 (0.57) | DPP4DPP8DPP9DPP7AKT1 | |
| SCHEMBL2375481 | 0.76 | OPRK1 (0.71) | DPP4OPRK1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1997046553-A1 | THROMBIN INHIBITORS | NOVARTIS AG (CH) | 1997-12-11 | — | — | WO | disclosed |